| Percentage of Cyclin D1 | Percentage of Ki67 | ||||
---|---|---|---|---|---|---|
Variants of Thyroid neoplasm | Immunolabelled tumor cells (%) | Immunolabelled tumor cells (%) | ||||
MSR | Mean ± SD | PPV | MSR | Mean ± SD | PPV | |
(Range) | (Range) | |||||
Papillary thyroid carcinoma (n = 59) | 48.5 | 42.9 ± 19.1 | 91.5 | 3.5 | 5.2 ± 5.7 | 76.3 |
(6.1–76.7) | (0.2–37.4) | |||||
Medullary thyroid carcinoma (n = 1) | 66.4 | 66.4 | 100 | 4 | 4 | 11.1 |
Follicular carcinoma (n = 9) | 34.2 | 36.0 ± 26.6 | 77.8 | 2.4 | 4.5 ± 6.1 | 28.6 |
(5.8–76) | (0.9–20.3) | |||||
Poorly differentiated thyroid carcinoma (n = 7) | 45.9 | 42.3 ± 21 | 85.7 | 4.1 | 5.4 ± 4.2 | 60 |
(2.8–68.1) | (0.3–12.2) | |||||
Well differentiated tumor-uncertain malignant potential (n = 2) | 41.5 | 41.5 ± 3.2 | 100 | 3.15 | 3.2 ± 2.9 | 50 |
(39.2–43.7) | (1.1–5.2) | |||||
Follicular adenoma (n = 7) | 13.1 | 17.5 ± 15.3 | 66.7 | 2.3 | 2.9 ± 1.9 | 20 |
(2.5–43.2) | (1–6.8) | |||||
Anaplastic thyroid carcinoma (n = 5) | 9.9 | 17.2 ± 19.5 | 33.3 | 10.4 | 8.3 ± 3.5 | 66.7 |
(1.9–49.7) | (4.4–11.7) | |||||
Background (inflammation or adenomatous goiter, n = 12) | 3.4 | 3.4 ± 0.9 |  | 3.05 | 3.7 ± 1.4 |  |
(2.1–5.2) | (2.1–7.2) |